Company / Operating Income
Ventyx Biosciences, Inc. Operating Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$148.4M
FY2024
5-year range
-$208.0M / -$7.0M
FY2020-FY2024
Trend
+28.6%
vs FY2023
Sector context
#114 of 202
Health Care
What the data says
At -$148M, Ventyx Biosciences, Inc.'s operating income ranks #114 of 202 in the Health Care sector. Operating Income returned to growth in FY2024 after 3 years of decline, reaching -$148M.
Based on SEC 10-K filings.
-$148M in FY2024.
Declined from -$113M to -$148M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 202 in Health CareTop 56% of 202This company -$148.4M Sector average $70.7M
▼
-310.0% below sector average
Key checks
Key Insights
- In FY2024, operating income increased 28.6% year-over-year.
- Ranks #114 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$148.4M | +28.6% |
| FY2023 | -$208.0M | -83.8% |
| FY2022 | -$113.1M | -68.5% |
| FY2021 | -$67.1M | -852.4% |
| FY2020 | -$7.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026